Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEDIPASVIR\SOFOSBUVIR Cause Product use issue? 89 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Product use issue have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.4% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.

89
Reports of Product use issue with LEDIPASVIR\SOFOSBUVIR
0.4%
of all LEDIPASVIR\SOFOSBUVIR reports
0
Deaths
24
Hospitalizations

How Dangerous Is Product use issue From LEDIPASVIR\SOFOSBUVIR?

Of the 89 reports, 24 (27.0%) required hospitalization, and 1 (1.1%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 89 reports have been filed with the FAERS database.

What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?

Fatigue (4,609) Headache (4,203) Nausea (1,471) Drug ineffective (1,397) Hepatitis c (1,076) Diarrhoea (1,065) Insomnia (1,021) Hepatocellular carcinoma (640) Vomiting (623) Dizziness (604)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Product use issue Risk?

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB

Related Pages

LEDIPASVIR\SOFOSBUVIR Full Profile All Product use issue Reports All Drugs Causing Product use issue LEDIPASVIR\SOFOSBUVIR Demographics